Paclitaxel shine diterpenoid alkaloid tare da aikin anticancer, wanda za'a iya fitar da shi daga tsire-tsire na taxaceae.Yana da ƙayyadaddun tsarin sinadarai na sabon labari, aiki mai fa'ida da fa'ida, sabbin hanyoyin aiki da ƙarancin albarkatun ƙasa.
Wahalar samarwapaclitaxelyafi zuwa daga abubuwa masu zuwa:
1, rashin albarkatu: albarkatun shukar Taxaceae da kansu suna da talauci sosai, kuma suna jinkirin girma, wanda ke sa saye da cirewar paclitaxel da wahala sosai.
2, tsarin cirewa da rabuwa yana da wuyar gaske: cirewar paclitaxel daga tsire-tsire na taxaceae yana buƙatar tafiya ta matakai masu yawa, ciki har da tarin tsire-tsire, cirewa, rabuwa, tsarkakewa, da dai sauransu, wanda ke buƙatar fasaha na fasaha da kayan aiki sosai.
3, haɗakar sinadarai yana da wahala: kodayake hanyar haɗin sinadarai na paclitaxel ya ɗan ɗan sami ɗan ci gaba, amma hanyar haɗin sa yana da tsayi, matakan haɓaka suna da yawa, buƙatar amfani da reagents masu tsada masu tsada, kuma yanayin halayen yana da wahalar sarrafawa. yawan amfanin ƙasa yana da ƙasa, bai dace da samar da masana'antu ba.
Saboda haka, domin warware matsalar samar dapaclitaxel, ya zama dole don ƙara zuba jari a cikin bincike da ci gaba na kimiyya da fasaha, bincika sabbin hanyoyin haɓakawa da haɓakawa, da haɓaka yawan amfanin ƙasa da haɓakar haɓaka.Har ila yau, ya zama dole a kare albarkatun harajin daji da inganta noman wucin gadi don biyan buƙatun kasuwa.
Lura: Abubuwan fa'idodi da aikace-aikacen da aka gabatar a cikin wannan labarin an samo su ne daga wallafe-wallafen da aka buga.
Yunnan Hande Biotechnology Co., Ltd. ya mai da hankali kan samar da paclitaxel na tsawon shekaru 26, kuma shi ne mai zaman kansa mai sana'a na maganin ciwon daji na paclitaxel API wanda ya amince da FDA ta Amurka, Turai EDQM, Australia TGA, China CFDA , Indiya, Japan da sauran hukumomin gudanarwa na kasa.Yunnan Hande paclitaxel, tabo wadata, masana'anta kai tsaye tallace-tallace, maraba don tambaya, 18187887160 (WhatsApp lamba iri ɗaya)
Lokacin aikawa: Oktoba-10-2023